Drug Profile
Metformin/rosuvastatin - Yuhan Corporation
Alternative Names: Rosumet; Rosuvastatin/metformin - Yuhan; YH-14755; YH-IMD3; YH_IMD3Latest Information Update: 29 Jan 2019
Price :
$50
*
At a glance
- Originator Yuhan
- Class Antihyperglycaemics; Antihyperlipidaemics; Biguanides; Cardiovascular therapies; Fluorobenzenes; Pyrimidines; Small molecules; Sulfonamides
- Mechanism of Action AMP activated protein kinase stimulants; Gluconeogenesis inhibitors; HMG-CoA reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Diabetes mellitus; Hyperlipidaemia